Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study

• Päätekijät: Najibah Galadanci (Tekijä), Shannon Phillips (Tekijä), Alyssa Schlenz (Tekijä), Nataliya Ivankova (Tekijä), Julie Kanter (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2024-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Newborn screening (NBS) for sickle cell disease (SCD) has significantly improved childhood survival but there are still gaps resulting in delayed care for affected infants. As a state-run program, there are no national quality assurance programs to ensure each state achieves consistent, reliable out...